This whitepaper illustrates how a commitment to connecting patients to their therapies and a sensitivity to the patient journey can make the difference between success and failure.
Nearly 75% of adults are nonadherent to prescription medications. The cost is estimated at $100-300 billion annually.
But do affordable and accessible patient-focused solutions exist?
This whitepaper illustrates how a commitment to connecting patients to their therapies and a sensitivity to the patient journey can make the difference between success and failure.
DC Roundtable: Patrick Cooney of The Federal Group Drops the Latest on PBM Legislation in Washington
April 11th 2024In this episode of "DC Roundtable," Peter Wehrwein, managing editor of Managed Healthcare Executive, spoke with Patrick Cooney, president of The Federal Group, a lobbying and strategic planning firm in Washington, D.C., about recent developments in Washington concerning PBMs.
Listen